Drug Type Small molecule drug |
Synonyms Camptothecin liposomal MediGene AG, ENDOTAG2, MBT-0312 + [1] |
Target |
Mechanism TOP1 inhibitors(DNA topoisomerase I inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Phase 1 | DE | - | |
Neoplasms | Preclinical | DE | 01 Apr 2004 | |
Neoplasms | Preclinical | DE | 01 Apr 2004 |